Related Experiment Video
Updated: Aug 12, 2026
12:21
The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
Steroid treatment improves cochlear function in the MRL.MpJ-Fas(lpr) autoimmune mouse
D R Trune1, R J Wobig, J B Kempton
1Oregon Hearing Research Center, Department of Otolaryngology - Head and Neck Surgery, Oregon Health Sciences University, NRC04, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098, USA. truned@ohsu.edu
Hearing Research
|November 5, 1999
Summary
This study introduces the autoimmune mouse as a model for steroid-responsive hearing loss. Prednisolone treatment improved hearing thresholds and survival rates in autoimmune mice, offering insights into treating sensorineural hearing loss.
Area of Science:
- Immunology
- Otolaryngology
- Pharmacology
Background:
- Autoimmune sensorineural hearing loss mechanisms are poorly understood.
- A lack of suitable animal models hinders research into steroid-responsive hearing loss.
Purpose of the Study:
- To evaluate the MRL.MpJ-Fas(lpr) autoimmune mouse as a model for steroid-responsive hearing loss.
- To examine the effects of prednisolone on auditory thresholds in this autoimmune mouse model.
Main Methods:
- Autoimmune mice (3.5-4.5 months) underwent auditory brainstem response (ABR) testing.
- Mice received prednisolone in drinking water for 2.5 months; controls received tap water.
- Post-treatment ABR evaluated changes in auditory thresholds.
Main Results:
- Prednisolone treatment significantly improved survival rates compared to controls.
- 50% of treated ears showed improved or stable cochlear function versus 25% in controls.
- Untreated controls experienced a 14.7 dB threshold increase; treated mice showed only a 4.3 dB increase.
Conclusions:
- The MRL.MpJ-Fas(lpr) mouse is a viable model for studying steroid-responsive mechanisms in hearing loss.
- Findings support the use of this model for research into autoimmune sensorineural hearing loss and steroid therapies.
- This model can advance understanding of hearing disorders benefiting from corticosteroid treatment.
